{"cord_uid":"l5kocy4f", "sourcedb":"PMC", "sourceid":"PMC5226679", "divid":0, "text":"Introduction Ebola (EBOV) and Marburg (MARV) viruses are virulent pathogens that cause severe hemorrhagic disease in humans and non-human primates. There are currently no FDA approved vaccines or antiviral drugs to prevent or treat infections by these Category A NIAID priority pathogens [1] . The recent catastrophic outbreak of EBOV in West Africa underscores the urgent need to better understand the biology and pathogenesis of this global public health threat, and to decipher the molecular mechanisms by which EBOV interacts with the host to cause disease.", "project":"cdlai_CORD-19", "denotations":[]}